Phibro Animal Health's total inventories for the quarter that ended in Sep. 2024 was $273 Mil. Phibro Animal Health's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Sep. 2024 was $269 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Phibro Animal Health's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was $-8.91.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Phibro Animal Health's Days Inventory for the
three
months ended in Sep. 2024 was 138.85.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Phibro Animal Health's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Phibro Animal Health's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 1.03.
Phibro Animal Health Total Inventories Historical Data
The historical data trend for Phibro Animal Health's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Phibro Animal Health (NAS:PAHC) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Phibro Animal Health's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Phibro Animal Health's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Phibro Animal Health Total Inventories Related Terms
Thank you for viewing the detailed overview of Phibro Animal Health's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PAHC has been successfully added to your 